Name
|
Auflagedatum
|
Volumen
|
YTD-P
|
1-Y-P
|
3-Y-P
|
5-Y-P
|
Invesco NASDAQ Biotech UCITS ETF
IE00BQ70R696
USD / Acc. / Retail
|
06.11.2014
10,7 Jahre
|
212,86 |
-13,62% |
-17,25% |
-5,04% |
-15,76% |
iShares Nasdaq US Biotechnology UCITS ETF
IE00BYXG2H39
USD / Acc. / Retail
|
19.10.2017
7,7 Jahre
|
364,74 |
-13,59% |
-17,23% |
-5,00% |
-15,78% |
Selectra J. Lamarck Biotech
LU0574993464
EUR / Acc. / Retail
|
10.01.2011
14,5 Jahre
|
57,49 |
-6,91% |
-17,02% |
-31,86% |
-36,48% |
HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund
LU1540961759
USD / Acc. / Retail
|
30.12.2011
13,5 Jahre
|
14,77 |
-15,28% |
-17,01% |
+0,36% |
-19,98% |
MEDICAL BioHealth
LU0119891520
EUR / Acc. / Retail
|
30.10.2000
24,7 Jahre
|
515,38 |
-13,26% |
-15,63% |
+10,74% |
-10,66% |
RH&PARTNER Investment Funds - RH&P Global Life Sciences Fund
LU0115986761
USD / Acc. / Retail
|
06.09.2000
24,9 Jahre
|
45,00 |
-14,45% |
-14,54% |
-11,82% |
-30,78% |
Polar Capital Funds PLC - Biotechnology Fund
IE00BF23BV98
USD / Dist. / Retail
|
31.10.2013
11,7 Jahre
|
1.414,23 |
-15,80% |
-13,37% |
+8,51% |
+22,82% |
Abaris Biotechnology Opportunities
LU2210105669
EUR / Acc. / Retail
|
09.11.2020
4,7 Jahre
|
12,86 |
-12,59% |
-13,02% |
+0,80% |
N/A |
L&G Pharma Breakthrough UCITS ETF
IE00BF0H7608
USD / Acc. / Retail
|
18.01.2018
7,5 Jahre
|
12,45 |
-6,90% |
-4,35% |
-19,72% |
-25,51% |